A250117P220000
- 0.00
- 0.000.00%
Agilent Technologies Newsroom
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Is the Options Market Predicting a Spike in Agilent (A) Stock?
Agilent Technologies | 10-K: FY2024 Annual Report
Leerink Partners Maintains Agilent Technologies(A.US) With Buy Rating, Raises Target Price to $155
UBS Says 'Underweight the Names With High China Exposure'
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Leerink Partners Adjusts Agilent Technologies Price Target to $155 From $150, Maintains Outperform Rating
Whole Genome Sequencing Market Report 2024-2034: Key Player Profiles for Agilent Technologies, BGI Group, Bio-Rad Laboratories, Eurofins Scientific, Illumina, Thermo Fisher Scientific & ProPhase Labs - ResearchAndMarkets.com
Catalyst Watch: FOMC Meeting, Govt. Funding Drama, Earnings for Micron, Nike, and FedEx
Agilent Technologies Announces Operational Restructuring Plan
Some Shareholders Feeling Restless Over Agilent Technologies, Inc.'s (NYSE:A) P/E Ratio
BofA Securities Maintains Agilent Technologies(A.US) With Hold Rating, Cuts Target Price to $150
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 PharmDx Receives European IVDR Certification
Agilent Gains 5% in a Month: Should You Buy, Sell or Hold the Stock?
Agilent Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $155
PD-L1 Tests Market Research Report 2024, Featuring F. Hoffmann-La Roche, Agilent Technologies, Amoy Diagnostics, BioGenex Laboratories - Segments, Share, Regulatory, Reimbursement and Forecast to 2036 - ResearchAndMarkets.com
Ready Capital Corporation Announces Pricing of Public Offering of Senior Notes Due 2029
NeuroSense Therapeutics Shares Climbed on $5M Private Placement
Here's What Analysts Are Forecasting For Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Results